Lapatinib, erlotinib, imatinib and nilotinib are potent reversal agents for MRP7 (ABCC10)-mediated multidrug resistance Conference Poster (Faculty180)

cited authors

  • Sodani, K; Tiwari, Amit K; Kuang, Y H; Shen, T; D'Ambra, T M; Lei, Y; Lee, J; Chen, X; Ashby, Charles Jr; Chen, Z S

publication date

  • 2009

presented at event